Keywords
Last Name
Institution

Alison Oliveto

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPsychiatry, College of Medicine
DivisionPSY Center for Addiction Research
Address441 Psychiatric Research Institute
4224 Shuffield Dr.
Mail Slot # 843
Little Rock AR 72205
Phone501-526-8441
vCardDownload vCard

    Collapse Research Funds 
    Collapse principal investigator
    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 1 R01 DA039088-01 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-02 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-03 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-04 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-05 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Treatment Outcomes for Prescription Opioid Dependence - Award Number: 5 R01 DA039088-05 - Total direct costs: $2,132,863 - Start Date: 2015-07-15

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Improving Buprenorphine Detoxification Outcomes with Isradipine - Award Number: 1 R21 DA035325-01 - Total direct costs: $275,000 - Start Date: 2013-04-15

    Pass Through Agency: Dartmouth College - Funding Agency: NIH/Nat. Inst. on Alcohol Abuse & Alcoholism - Title: Family Bases Contingency Management for Adolescent Alcohol Abuse - Award Number: 7 R01 AA016917-06 - Total direct costs: $22,928 - Start Date: 2012-06-05

    Funding Agency: NIH/Nat. Inst. on Drug Abuse - Title: Impact of CYP2D6 Phenotype on Response to Methamphetamine in Humans - Award Number: 1 R21 DA031837-01A1 - Total direct costs: $392,501 - Start Date: 2012-05-01


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bashiri M, Greenfield LJ, Oliveto A. Telemedicine Interest for Routine Follow-Up Care Among Neurology Patients in Arkansas. Telemed J E Health. 2016 Jun; 22(6):514-8. PMID: 26684500.
      View in: PubMed
    2. Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014 Apr; 34(2):234-9. PMID: 24525654; PMCID: PMC4068618.
    3. Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. Exp Clin Psychopharmacol. 2013 Aug; 21(4):294-302. PMID: 23855333; PMCID: PMC3972066.
    4. Atkinson TS, Sanders N, Mancino M, Oliveto A. Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. J Addict Med. 2013 Jul-Aug; 7(4):243-8. PMID: 23648640; PMCID: PMC3737260.
    5. Oliveto A, Mancino M, Sanders N, Cargile C, Benjamin Guise J, Bickel W, Brooks Gentry W. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. Eur J Pharmacol. 2013 Sep 05; 715(1-3):424-35. PMID: 23524089; PMCID: PMC3759565.
    6. Oliveto A, Poling J, Mancino MJ, Williams DK, Thostenson J, Pruzinsky R, Gonsai K, Sofuoglu M, Gonzalez G, Tripathi S, Kosten TR. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 2012 Jan; 107(1):131-41. PMID: 21707811; PMCID: PMC3237722.
    7. Mancino MJ, Gentry BW, Feldman Z, Mendelson J, Oliveto A. Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study. Am J Drug Alcohol Abuse. 2011 Mar; 37(2):131-6. PMID: 21219261; PMCID: PMC3063384.
    8. Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend. 2011 Jan 15; 113(2-3):184-91. PMID: 20828943; PMCID: PMC3005977.
    9. Oliveto A, Gentry WB, Pruzinsky R, Gonsai K, Kosten TR, Martell B, Poling J. Behavioral effects of gamma-hydroxybutyrate in humans. Behav Pharmacol. 2010 Jul; 21(4):332-42. PMID: 20526195; PMCID: PMC2911496.
    10. Mancino MJ, McGaugh J, Feldman Z, Poling J, Oliveto A. Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis. Am J Addict. 2010 Mar-Apr; 19(2):169-77. PMID: 20163389; PMCID: PMC3472706.
    11. Oliveto A, Pruzinsky R, Poling J, Gentry WB, Martell B, Gonsai K, Kosten TR. Behavioral effects of GHB in humans. Behavioural Pharmacology. 2010; 21(4):332-42.
    12. McGaugh J, Mancino MJ, Feldman Z, Chopra MP, Gentry WB, Cargile C, Oliveto A. Open-label pilot study of modafinil for methamphetamine dependence. J Clin Psychopharmacol. 2009 Oct; 29(5):488-91. PMID: 19745650; PMCID: PMC3610177.
    13. Chopra MP, Feldman Z, Mancino MJ, Oliveto A. Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis. Pharmacol Biochem Behav. 2008 Oct; 90(4):787-96. PMID: 18585405; PMCID: PMC2577173.
    14. Chopra M.P, Feldman Z.L, Mancino M.J, Oliveto A. Response to naloxone versus placebo in opioid-dependent humans responding under a naloxone discrimination procedure: influences of sex and opioid maintenance dose. Pharmacology, Biochemistry and Behavior. 2008; 90(4):787-96.
    15. Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Oliveto A, Kosten TR. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Exp Clin Psychopharmacol. 2007 Oct; 15(5):453-60. PMID: 17924779.
      View in: PubMed
    16. Poling J, Pruzinsky R, Kosten TR, Gonsai K, Sofuoglu M, Gonzalez G, Oliveto A. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. Am J Addict. 2007 May-Jun; 16(3):187-94. PMID: 17612822.
      View in: PubMed
    17. González G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, Kosten TR. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007 Feb 23; 87(1):1-9. PMID: 16930857.
      View in: PubMed
    18. Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology. 2006 Mar; 31(3):644-50. PMID: 16123763.
      View in: PubMed
    19. Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry. 2006 Feb; 63(2):219-28. PMID: 16461866.
      View in: PubMed
    20. Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005 Aug 01; 79(2):157-65. PMID: 16002025.
      View in: PubMed
    21. Kosten T, Sofuoglu M, Poling J, Gonsai K, Oliveto A. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. Am J Addict. 2005 Jan-Feb; 14(1):8-17. PMID: 15804873.
      View in: PubMed
    22. Hughes JR, Oliveto AH, Riggs R, Kenny M, Liguori A, Pillitteri JL, MacLaughlin MA. Concordance of different measures of nicotine dependence: two pilot studies. Addict Behav. 2004 Nov; 29(8):1527-39. PMID: 15451122.
      View in: PubMed
    23. Oliveto A, Poling J, Kosten TR, Gonsai K. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. Eur J Pharmacol. 2004 May 03; 491(2-3):157-68. PMID: 15140632.
      View in: PubMed
    24. Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother. 2004 Apr; 5(4):713-25. PMID: 15102558.
      View in: PubMed
    25. Kosten T, Falcioni J, Oliveto A, Feingold A. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. Am J Addict. 2004 Mar-Apr; 13(2):191-201. PMID: 15204669.
      View in: PubMed
    26. Kosten T.R, Falcioni J, Oliveto A, Feingold A. Depression predicts poor treatment response with desipramine and methadone or buprenorphine among cocaine and opioid dependent patients. American Journal on the Addictions. 2004; 13(2):191-201.
    27. Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction. 2003 Nov; 98(11):1625-32. PMID: 14616189.
      View in: PubMed
    28. Oliveto A, Benios T, Gonsai K, Feingold A, Poling J, Kosten TR. D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. Exp Clin Psychopharmacol. 2003 Aug; 11(3):237-46. PMID: 12940503.
      View in: PubMed
    29. Gonzalez G, Feingold A, Oliveto A, Gonsai K, Kosten TR. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. Am J Drug Alcohol Abuse. 2003 Aug; 29(3):497-514. PMID: 14510037.
      View in: PubMed
    30. Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav. 2003 Jul; 75(4):801-8. PMID: 12957222.
      View in: PubMed
    31. Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 2003 Jun 05; 70(3):315-25. PMID: 12757969.
      View in: PubMed
    32. Kosten T, Poling J, Oliveto A. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients. Addiction. 2003 May; 98(5):665-71. PMID: 12751984.
      View in: PubMed
    33. Oliveto A, Sevarino K, McCance-Katz E, Benios T, Poling J, Feingold A. Clonidine and yohimbine in opioid-dependent humans responding under a naloxone novel-response discrimination procedure. Behav Pharmacol. 2003 Mar; 14(2):97-109. PMID: 12658070.
      View in: PubMed
    34. Kosten TR, Oliveto A, Sevarino KA, Gonsai K, Feingold A. Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug Alcohol Depend. 2002 Apr 01; 66(2):173-80. PMID: 11906804.
      View in: PubMed
    35. Feingold A, Oliveto A, Schottenfeld R, Kosten TR. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. Am J Addict. 2002; 11(2):111-23. PMID: 12028741.
      View in: PubMed
    36. Gonzalez G, Oliveto A, Kosten TR. Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Drugs. 2002; 62(9):1331-43. PMID: 12076182.
      View in: PubMed
    37. Oliveto A, Sevarino K, McCance-Katz E, Feingold A. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure. Pharmacol Biochem Behav. 2002 Jan-Feb; 71(1-2):85-96. PMID: 11812511.
      View in: PubMed
    38. Oliveto A, McCance-Katz FE, Singha A, Petrakis I, Hameedi F, Kosten TR. Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug Alcohol Depend. 2001 Jul 01; 63(2):155-67. PMID: 11376920.
      View in: PubMed
    39. Singha AK, McCance-Katz EF, Petrakis I, Kosten TR, Oliveto A. Sex differences in self-reported and physiological response to oral cocaine and placebo in humans. Am J Drug Alcohol Abuse. 2000 Nov; 26(4):643-57. PMID: 11097197.
      View in: PubMed
    40. Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR. Thrice-weekly versus daily buprenorphine maintenance. Biol Psychiatry. 2000 Jun 15; 47(12):1072-9. PMID: 10862807.
      View in: PubMed
    41. Hughes JR, Oliveto AH, MacLaughlin M. Is dependence on one drug associated with dependence on other drugs? The cases of alcohol, caffeine and nicotine. Am J Addict. 2000; 9(3):196-201. PMID: 11000915.
      View in: PubMed
    42. Sevarino KA, Oliveto A, Kosten TR. Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development. Ann N Y Acad Sci. 2000; 909:51-87. PMID: 10911924.
      View in: PubMed
    43. Singha AK, McCance-Katz EF, Heck SA, Kosten TR, Oliveto A. Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Exp Clin Psychopharmacol. 1999 Nov; 7(4):391-8. PMID: 10609974.
      View in: PubMed
    44. Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Arch Gen Psychiatry. 1999 Sep; 56(9):812-20. PMID: 12884887.
      View in: PubMed
    45. Hughes JR, Oliveto AH, Liguori A, Carpenter J, Howard T. Endorsement of DSM-IV dependence criteria among caffeine users. Drug Alcohol Depend. 1998 Oct 01; 52(2):99-107. PMID: 9800139.
      View in: PubMed
    46. O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, Schottenfeld RS. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998 Aug; 105(2):100-5. PMID: 9727815.
      View in: PubMed
    47. Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol. 1998 May; 9(3):207-17. PMID: 9832935.
      View in: PubMed
    48. Oliveto AH, Rosen MI, Kosten TA, Hameedi FA, Woods SW, Kosten TR. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Exp Clin Psychopharmacol. 1998 May; 6(2):169-78. PMID: 9608349.
      View in: PubMed
    49. Oliveto AH, Farren C, Kosten TR. Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study. Am J Addict. 1998; 7(4):272-82. PMID: 9809131.
      View in: PubMed
    50. Oliveto A.H, Rosen M, Kosten T.A, Hameedi F, Woods S, Kosten T.R. Naloxone discrimination in opioid-dependent humans under a novel-response discrimination procedure. Experimental and Clinical Psychopharmacology. 1998; (6):169-178.
    51. Hughes JR, Oliveto AH. A systematic survey of caffeine intake in Vermont. Exp Clin Psychopharmacol. 1997 Nov; 5(4):393-8. PMID: 9386966.
      View in: PubMed
    52. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug; 54(8):713-20. PMID: 9283506.
      View in: PubMed
    53. Liguori A, Hughes JR, Oliveto AH. Caffeine self-administration in humans: 1. Efficacy of cola vehicle. Exp Clin Psychopharmacol. 1997 Aug; 5(3):286-94. PMID: 9260077.
      View in: PubMed
    54. Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Badger G. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans. Behav Pharmacol. 1997 Jun; 8(2-3):124-38. PMID: 9833008.
      View in: PubMed
    55. Oliveto A.H, Kosten T. R. New Treatments for Opiate Dependence. Buprenorphine. 1997.
    56. O'Connor PG, Oliveto AH, Shi JM, Triffleman E, Carroll KM, Kosten TR, Rounsaville BJ. A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. Am J Drug Alcohol Abuse. 1996 Nov; 22(4):523-31. PMID: 8911590.
      View in: PubMed
    57. Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH, Price LH. Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry. 1996 Jan 15; 39(2):147-8. PMID: 8717615.
      View in: PubMed
    58. Best S.E, Oliveto A.H, Kosten T.R. Opioid Addiction: Recent Advances in Detoxification and Maintenance Therapy. CNS Drugs. 1996; (6):301-304.
    59. Hughes J.H, Oliveto A.H, Higgins S.T, Bickel W.K, Terry S.Y. Saying vs. doing and other methodological issues in the study of human drug self-administration. Experimental and Clinical Psychopharmacology. 1996; (4):234-238.
    60. Oliveto A, Kosten TR, Schottenfeld R, Falcioni J, Ziedonis D. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. J Subst Abuse Treat. 1995 Nov-Dec; 12(6):423-8. PMID: 8749726.
      View in: PubMed
    61. Kamien JB, Bickel WK, Oliveto AH, Higgins ST, Hughes JR, Richards AT, Badger GJ. Placebo-effects contribute to differences in the acquisition of drug discrimination by humans: a retrospective analysis. Behav Pharmacol. 1995 Mar; 6(2):187-194. PMID: 11224326.
      View in: PubMed
    62. Kamien JB, Bickel WK, Oliveto AH, Higgins ST, Hughes JR, Richards AT, Badger GJ. Placebo-effects contribute to differences in the acquisition of drug discrimination by humans: a retrospective analysis. Behav Pharmacol. 1995; 6(2):187 - 194.
    63. Hale K.L, Hughes J.R, Oliveto A.H, Higgins S.T. Caffeine self-administration and subjective effects in adolescents. Experimental and Clinical Psychopharmacology. 1995; (3):364-370.
    64. Hughes, J.R, Oliveto A.H, Bickel W.K, Higgins S.T, Badger G.J. The ability of low doses of caffeine to serve as reinforcers in humans: A replication. Experimental and Clinical Psychopharmacology. 1995; (3):1-6.
    65. Oliveto AH, Rosen MI, Woods SW, Kosten TR. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. J Pharmacol Exp Ther. 1995 Jan; 272(1):231-41. PMID: 7815337.
      View in: PubMed
    66. Kamien JB, Bickel WK, Oliveto AH, Smith BJ, Higgins ST, Hughes JR, Badger GJ. Triazolam discrimination by humans under a novel response procedure: effects of buspirone and lorazepam. Behav Pharmacol. 1994; 5(3):315 - 325.
    67. Kamien JB, Bickel WK, Oliveto AH, Smith BJ, Higgins ST, Hughes JR, Badger GJ. Triazolam discrimination by humans under a novel response procedure: effects of buspirone and lorazepam. Behav Pharmacol. 1994 Jun; 5(3):315-325. PMID: 11224281.
      View in: PubMed
    68. Oliveto AH, Bickel WK, Kamien JB, Hughes JR, Higgins ST. Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology (Berl). 1994 Apr; 114(3):417-23. PMID: 7531852.
      View in: PubMed
    69. Oliveto A.H, Kosten T.R, Schottenfeld R, Ziedonis D, Falcioni J. Cocaine use in buprenorphine- vs methadone-maintained cocaine users. American Journal of Addictions. 1994; (3):43-48.
    70. Oliveto A, Kosten T, Schottenfeld R, Ziedonis D. Cocaine abuse among methadone-maintained patients. Am J Psychiatry. 1993 Nov; 150(11):1755. PMID: 8214197.
      View in: PubMed
    71. Oliveto AH, Bickel WK, Hughes JR, Terry SY, Higgins ST, Badger GJ. Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone. Behav Pharmacol. 1993; 4(3):237 - 246.
    72. Oliveto AH, Bickel WK, Hughes JR, Terry SY, Higgins ST, Badger GJ. Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone. Behav Pharmacol. 1993 Jun; 4(3):237-246. PMID: 11224191.
      View in: PubMed
    73. Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ. Caffeine self-administration and withdrawal: incidence, individual differences and interrelationships. Drug Alcohol Depend. 1993 May; 32(3):239-46. PMID: 8348875.
      View in: PubMed
    74. Hughes JR, Oliveto AH. Coffee and alcohol intake as predictors of smoking cessation and tobacco withdrawal. J Subst Abuse. 1993; 5(3):305-10. PMID: 8312736.
      View in: PubMed
    75. Bickel WK, Oliveto AH, Kamien JB, Higgins ST, Hughes JR. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. J Pharmacol Exp Ther. 1993 Jan; 264(1):360-7. PMID: 8423538.
      View in: PubMed
    76. Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther. 1992 Jun; 261(3):885-94. PMID: 1602393.
      View in: PubMed
    77. Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Fenwick JW. Triazolam as a discriminative stimulus in humans. Drug Alcohol Depend. 1992 Jun; 30(2):133-42. PMID: 1633753.
      View in: PubMed
    78. Oliveto AH, Hughes JR, Higgins ST, Bickel WK, Pepper SL, Shea PJ, Fenwick JW. Forced-choice versus free-choice procedures: caffeine self-administration in humans. Psychopharmacology (Berl). 1992; 109(1-2):85-91. PMID: 1365676.
      View in: PubMed
    79. Hughes JR, Oliveto AH, Helzer JE, Higgins ST, Bickel WK. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10? Am J Psychiatry. 1992 Jan; 149(1):33-40. PMID: 1728182.
      View in: PubMed
    80. Oliveto AH, Hughes JR, Terry SY, Bickel WK, Higgins ST, Pepper SL, Fenwick JW. Effects of caffeine on tobacco withdrawal. Clin Pharmacol Ther. 1991 Aug; 50(2):157-64. PMID: 1868677.
      View in: PubMed
    81. Oliveto AH, Picker MJ, Dykstra LA. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation. J Pharmacol Exp Ther. 1991 Apr; 257(1):8-18. PMID: 1850479.
      View in: PubMed
    82. Hughes JR, Oliveto AH. The growth of treatment research in alcohol and drug use disorders: a computerized literature search. Drug Alcohol Depend. 1990 Aug; 26(1):81-4. PMID: 2209418.
      View in: PubMed
    83. Oliveto AH, Hughes JR, Pepper SL, Bickel WK, Higgins ST. Low doses of caffeine can serve as reinforcers in humans. NIDA Res Monogr. 1990; 105:442. PMID: 1876066.
      View in: PubMed
    84. Picker MJ, Cleary JP, Berens K, Oliveto AH, Dykstra LA. Molindone: effects in pigeons responding under conditional discrimination tasks. Pharmacol Biochem Behav. 1989 Feb; 32(2):439-45. PMID: 2727003.
      View in: PubMed
    85. Oliveto A, Picker M, Dykstra LA. Effects of mixed-action opioids on food-maintained behavior of morphine-pretreated and morphine-tolerant rats. NIDA Res Monogr. 1989; 95:524. PMID: 2561847.
      View in: PubMed
    86. Oliveto AH, Slifer BL, Dykstra LA. Tripelennamine fails to enhance the morphine-like stimulus effects of pentazocine. Pharmacol Biochem Behav. 1988 Feb; 29(2):397-401. PMID: 3362933.
      View in: PubMed
    87. Oliveto AH, Dykstra LA. Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists. Psychopharmacology (Berl). 1988; 95(3):339-43. PMID: 3137619.
      View in: PubMed
    88. Oliveto AH, Dykstra LA. Naloxone sensitivity in squirrel monkeys under a schedule of shock titration. Pharmacol Biochem Behav. 1987 Jan; 26(1):191-3. PMID: 3562492.
      View in: PubMed
    89. Oliveto A, Feldman Z, Mancino, M.J. Alcohol dependence diagnosis influences response to disulfiram in dually cocaine- and opioid-dependent humans maintained on methadone. 70th Annual Meeting of the College on Problems of Drug Dependence.
    90. Mancino, M.J., Feldman, Z., Oliveto A. Gender differences in response to disulfiram treatment for cocaine dependence in methadone-stabilized opioid- and cocaine-dependent individuals. 70th Annual Meeting of the College on Problems of Drug Dependence.
    91. McGaugh, J.D., Mancino, M., Gentry, W.B., Chopra, M., Cargile, C., Oliveto A. Open label modafinil for methamphetamine dependence: Safety and tolerability. 70th Annual Meeting of the College on Problems of Drug Dependence.
    Oliveto's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _